Ethically, patients and surrogates are free to choose to deactivate antitachycardia function.S14-11 S14-13 Most patients only elect deactivation of the anti- tachycardia functions while leaving the pacing function on. Even at the end of life, pacing (either for bradycardia or for resynchronization therapy) may be an important aspect of the patient s QoL and may facilitate more alert and meaningful personal interactions. These differences are easily misunderstood, so they need careful explanation. 15. SHARED DECISION-MAKING Recommendations for Shared Decision-Making References that support the recommendations are summarized in Online Data Supplement 60. COR LOE Recommendations I B-NR In patients with VA or at increased risk for SCD, clinicians should adopt a shared decision-making approach in which treatment decisions are based not only on the best available evidence but also on the patients health goals, preferences, and I B-NR Patients considering implantation of a new ICD or replacement of an existing ICD for a low battery should be informed of their individual risk of SCD and nonsudden death from HF or noncardiac conditions and the effectiveness, safety, and potential complications of the ICD in light of their health goals, preferences, and CLINICAL STATEMENTS AND GUIDELINES Synopsis During most of their lives, people prefer to do everything possible to prevent SCD and prolong life. However, many people may get to a point in their lives where SCD is not the worst outcome. Patients may report a desire to die in their sleep.S15-6 Decisions related to SCD can be quite emotional; according to the patient s wishes, shared de- cision regarding end-of-life therapy making may involve caregivers such as family members or friends. Recommendation-Specific Supportive Text 1. Consideration of patient preferences is impor- tant for VA diagnosis and management deci- sions. 